152 related articles for article (PubMed ID: 9626178)
1. EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension.
Prié S; Stewart DJ; Dupuis J
Circulation; 1998 Jun; 97(21):2169-74. PubMed ID: 9626178
[TBL] [Abstract][Full Text] [Related]
2. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension.
Jasmin JF; Lucas M; Cernacek P; Dupuis J
Circulation; 2001 Jan; 103(2):314-8. PubMed ID: 11208695
[TBL] [Abstract][Full Text] [Related]
4. Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.
Mam V; Tanbe AF; Vitali SH; Arons E; Christou HA; Khalil RA
J Pharmacol Exp Ther; 2010 Feb; 332(2):455-62. PubMed ID: 19915069
[TBL] [Abstract][Full Text] [Related]
5. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG
Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
7. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
Ozturk EI; Uma S
J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
[TBL] [Abstract][Full Text] [Related]
8. Effect of ET(A) receptor antagonist on pulmonary hypertension and vascular reactivity in rats with congestive heart failure.
Lucas M; Jasmin JF; Dupuis J
Pulm Pharmacol Ther; 2001; 14(4):307-14. PubMed ID: 11440559
[TBL] [Abstract][Full Text] [Related]
9. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
Jasmin JF; Cernacek P; Dupuis J
Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
[TBL] [Abstract][Full Text] [Related]
10. Role of ET(A) receptors in the regulation of vascular reactivity in rats with congestive heart failure.
Thorin E; Lucas M; Cernacek P; Dupuis J
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H844-51. PubMed ID: 10924085
[TBL] [Abstract][Full Text] [Related]
11. [Angiotensin-(1-7) improves endothelium-dependent vasodilation in rats with monocrotaline-induced pulmonary arterial hypertension].
Liu XX; Chen AD; Pan Y; Zhang F; Qi ZB; Cao N; Han Y
Sheng Li Xue Bao; 2023 Aug; 75(4):497-502. PubMed ID: 37583036
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
13. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.
Barton M; Haudenschild CC; d'Uscio LV; Shaw S; Münter K; Lüscher TF
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14367-72. PubMed ID: 9826706
[TBL] [Abstract][Full Text] [Related]
14. Chronic blockade of endothelin ETA receptors improves flow dependent dilation in resistance arteries of hypertensive rats.
Iglarz M; Matrougui K; Lévy BI; Henrion D
Cardiovasc Res; 1998 Sep; 39(3):657-64. PubMed ID: 9861309
[TBL] [Abstract][Full Text] [Related]
15. Prolonged blockade of endothelin ET(A) receptors decreases vascular reactivity in the aorta of spontaneously hypertensive rats in vitro.
Iglarz M; Lévy BI; Henrion D
J Cardiovasc Pharmacol; 1999 Sep; 34(3):354-8. PubMed ID: 10470992
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
Nakazawa H; Hori M; Ozaki H; Karaki H
Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
[TBL] [Abstract][Full Text] [Related]
17. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
[TBL] [Abstract][Full Text] [Related]
18. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs.
Morio Y; Homma N; Takahashi H; Yamamoto A; Nagaoka T; Sato K; Muramatsu M; Fukuchi Y
J Vasc Res; 2007; 44(4):325-35. PubMed ID: 17438361
[TBL] [Abstract][Full Text] [Related]
19. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
20. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
